B. Valenzuela

发表

B. Valenzuela, B. A. Valenzuela, 2013 .

The influence of active secretion processes on intestinal absorption of salbutamol in the rat.

A. Nácher, V. Casabó, B. Valenzuela, 2001, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Design and characterization of a noncompetitive antagonist of the transient receptor potential vanilloid subunit 1 channel with in vivo analgesic and anti-inflammatory activity.

C. Belmonte, S. Ferroni, A. Fernández-Carvajal, 2006, The journal of pain : official journal of the American Pain Society.

Docosahexaenoic Acid (DHA), in the Prevention and Treatment of Neurodegenerative Diseases

B. Valenzuela, B. A. Valenzuela, Rodrigo Valenzuela, 2011 .

Profile of P-glycoprotein distribution in the rat and its possible influence on the salbutamol intestinal absorption process.

A. Nácher, B. Valenzuela, D. Barettino, 2004, Journal of pharmaceutical sciences.

Ácidos grasos poliinsaturados decadenalargaω-3y enfermedad cardiovascular N-3longchainpolyunsaturated fatty acids and cardiovascular disease

C. Sanhueza, B. Valenzuela, B. A. Valenzuela, 2014 .

Absorción de aceite en alimentos fritos Oil absorption in fried foods

B. Valenzuela, I. Morales, O. Montes, 2016 .

An Inhibitor of Neuronal Exocytosis (DD04107) Displays Long-Lasting In Vivo Activity against Chronic Inflammatory and Neuropathic Pain

V. Felipo, A. Ferrer-Montiel, O. Cauli, 2012, Journal of Pharmacology and Experimental Therapeutics.

Modelling intestinal absorption of salbutamol sulphate in rats.

J. Pérez-Ruixo, A. Nácher, V. Casabó, 2006, International journal of pharmaceutics.